(NSAIDS)

(NSAIDS)
Slide Note
Embed
Share

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) play a crucial role in managing inflammation by blocking inflammatory mediators. This includes the inhibition of enzymes like PLA2 & Cox, as well as the selective or non-selective inhibition of COX-1 and COX-2. NSAIDs have various pharmacological actions such as analgesic, antipyretic, and anti-inflammatory effects, making them valuable in treating conditions like fever, headache, arthritis, and more. Explore the mechanisms of action and therapeutic uses of NSAIDs in this informative content.

  • NSAIDs
  • Inflammatory Response
  • Pharmacology
  • Anti-Inflammatory
  • Therapeutic Uses

Uploaded on Feb 13, 2025 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) Dr Sasan Zaeri (PharmD, PhD) Department of Pharmacology

  2. Inflammatory cascade Triggers Infection Tissue and/or vessel damage Inflammatory Mediators Acute Inflammatory Response Note this is a common & non-specific response - Redness - Heat - Swelling - Pain

  3. Drugs block production or effect of inflammatory mediators Tissue and/or vessel damage Infection Inflammatory Mediators o Vasoactive peptides: Histamine,serotonin o The kinin system o Coagulation cascade o The complement system NSAIDs Corticosteroids o Arachidonic Acid metabolites

  4. Inflammatory Enzymes: PLA2 &COX 3. Zileuton Montelukast, zafirlukast 2.NSAIDS 1. Steroids Phospholipase A2 Arachidonic acid (AA) Cyclooxygenase (COX) Lipoxygenase Lipoxygenase products (leukotrienes) Prostaglandins & thromboxanes Inflammatory effects (inducible) Homeostatic Functions (stomach mucus) Inflammatory effects (esp. in asthma)

  5. COX-1 vs. COX-2

  6. NSAIDS- MECHANISM OF ACTION Non Selective NSAIDs inhibit both COX-1 & COX-2 reversibly Ibuprofen, Diclofenac, Indomethacin, Naproxen, Mefenamic acid etc. Aspirin (irreversible COX inhibitor) Selective NSAIDs inhibit only COX-2 reversibly Celecoxib

  7. Pharmacological Actions of Non- Selective NSAIDs Analgesic Antipyretic (Drug that lowers the elevated body temperature to normal) Anti-inflammatory Anti-platelet Exceptions: celecoxib, non-acetylated salicylates

  8. THERAPEUTIC USES SHARED BY NS- NSAIDs Fever Analgesic Headache Migraine Dental pain Common cold

  9. THERAPEUTIC USES SHARED BY NS- NSAIDs Rheumatoid arthritis Osteoarthritis Myositis or other forms of inflammatory conditions Dysmenorrhea

  10. ADVERSEEFFECTSSHAREDBY NS-NSAIDS GIT upsets ( nausea, vomiting) GIT bleeding & ulceration Bleeding Hypersensitivity reaction Inhibition of uterine contraction Salt & water retention

  11. DOSE DEPENDENT THERAPEUTIC EFFECTS OF ASPIRIN Anti-inflammatory Antipyretic, Analgesic Antithrombotic 0 1 2 3 4 5 Daily dose of aspirin (g)

  12. Blood Vessel Wall Endothelial Cell (COX-2) Platelet (COX-1) Arachidonic acid Arachidonic acid PGH2 PGH2 Prostacyclin (PGI2) Thromboxane (TXA2) cAMP/vessel smooth muscle relaxes Ca2+ aggregation cAMP aggregation Ca2+/vessel smooth muscle constricts Normal physiologic interaction between PGI2 and TXA2 in platelet and endothelial cell biology

  13. ADDEDCLINICALUSES Antiplatelet/Antithrombotic effect Decreases platelet production of TXA2 by COX-1 irreversibly to limit platelet aggregation and vasoconstriction Cardioprotective (reducing the risk of MI)

  14. Acute rheumatic fever Prevention of pre-eclampsia Chronic gouty arthritis with large doses Chronic use of small doses , reduce the incidence of cancer colon

  15. Adverse Effects Related to : (A) Therapeutic Doses Of Aspirin Aspirin asthma Reye's syndrome Syndrome of hepatic injury & encephalopathy in kids treated with aspirin after a viral illness

  16. Aspirin-induced asthma

  17. Adverse Effects Related to ( B) LARGEDOSESORPROLONGED USEOFASPIRIN Salicylism ( ringing of ear( tinnitus) , vertigo) Hyperthermia GI ulcer and bleeding Metabolic acidosis

  18. ADVERSE EFFECTS RELATEDTO HIGH DOSES

  19. CONTRAINDICATIONS Children with viral infections Patients with GI ulcer or upper GI bleeding Patients with hemophilia Patients with Aspirin-induced asthma

  20. PARACETAMOL (acetaminophen) Commonly used as analgesic antipyretic drug

  21. CLINICALUSESOFPARACETAMOL Can be used safely in patients with: Peptic or gastric ulcers Bleeding tendency Allergy to aspirin Viral infections in children Pregnancy

  22. ADVERSE EFFECTS Mainly on liver due to its active metabolite ( N-acetyl-p-benzoquinone) Large doses cause liver necrosis Treatment Of toxicity of paracetamol: N- acetylcysteine : SH- donor to neutralize the toxic metabolite

  23. ACETAMINOPHEN TOXICITY Acetaminophen UDP glucuronosyl- transferase Sulfotransferase glucuronide sulfate CYP2E1 induction alcohol Acetylcysteine (antidote) Glutathione-S- transferase Liver failure protein glutathione

  24. DICLOFENAC Clinical uses o Treatment of rheumatoid arthritis , osteoarthritis (accumulates in synovial fluid in Long-term use ) o Analgesic o Antipyretic o Acute gouty arthritis o Locally to prevent post-operative ophthalmic inflammation

  25. SELECTIVE COX-2 INHIBITORS General advantages : o Adverse effects are slighter than other NSADs o No effect on platelet aggregation (COX-1) o Long-term studies of the incidence of clinically significant gastrointestinal ulcers and bleeding are not yet completed

  26. ADVERSEEFFECTS Renal toxicity Cardiovascular (high risk of MI) Rofecoxib and valdecoxib were withdrawn

  27. STILL ON THE MARKET

  28. GENERAL CLINICAL USES Rheumatoid arthritis Osteoarthritis Acute musculoskeletal pain Dysmenorrhea They can also be used in patients with gastric ulcer , haemophilia for the above indications

More Related Content